Does Chagas disease present a health risk to Canadians?
(McGill University Health Centre) Believe it or not, a tropical blood parasite native to Latin America could be harmful to Canadians. Infectious diseases like malaria or Zika may have dominated recent headlines but Chagas -- the 'Kissing Bug' disease -- is in the spotlight following the publication of a new case study in the Canadian Medical Association Journal. Experts from Winnipeg and Montreal warn natives of Latin America and their offspring are at risk of contracting Chagas disease. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - December 13, 2017 Category: Infectious Diseases Source Type: news
Discovery of a potential therapeutic target to combat trypanosomes
(CNRS) Using cryo-electron microscopy, French researchers at the Institut de Biologie Mol é culaire et Cellulaire (CNRS/Universit é de Strasbourg) have analyzed the structure of trypanosomes parasites in details and revealed one of their potential weak points, which has remained undetected until now. This discovery opens the path to the development of new safer therapies that are less toxic and more specific against trypanosomes, the parasites causing the Chagas disease and the African sleeping sickness. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - October 26, 2017 Category: Biology Source Type: news
Increasing Acai Sales Demands Vigilance for Chagas Disease Increasing Acai Sales Demands Vigilance for Chagas Disease
Every year, Brazil registers between 110 and 150 new cases of the disease. Confirmation of oral transmission involves a parasitologic examination and epidemiologic evidence.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 13, 2017 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news
Discovering potential therapeutic protein inhibitors for Chagas disease
(Tokyo Institute of Technology) Scientists at Tokyo Institute of Technology (Tokyo Tech), Nagasaki University have identified four potential protein inhibitors and unlocked drug discovery strategies for the treatment of Chagas disease by using advanced three-dimensional computer simulation by supercomputer TSUBAME in combination with in vitro experiments and X-ray crystallography. Through this " smart drug discovery " in which IT drug discovery and biochemical experiments cooperate, they identified hit compounds for target protein with a hit rate of 20 times or more than conventional High Throughput Screening (HTS) methods...
Source: EurekAlert! - Medicine and Health - September 26, 2017 Category: International Medicine & Public Health Source Type: news
Scientists identify new hosts for Chagas Disease vectors
(University of California - Riverside) Solitary weasel-like animals called tayra might look pretty harmless, but some may actually be incubators for a parasite that causes Chagas disease, a chronic, debilitating condition that is spread by insects called kissing bugs and affects more than 8 million people worldwide. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - September 18, 2017 Category: Infectious Diseases Source Type: news
Abbott Prism Chagas
The ABBOTT PRISM Chagas assay is an in vitro chemiluminescent immunoassay (ChLIA) for the qualitative detection of antibodies to Trypanosoma cruzi (T cruzi), the causative agent of Chagas disease, in human serum and plasma specimens. (Source: What's New at CBER)
Source: What's New at CBER - September 11, 2017 Category: Biomedical Science Source Type: news
Drug For 'Neglected' Chagas Disease Gains FDA Approval Amid Price Worries
U.S. doctors treating Chagas disease have long wanted FDA approval for a treatment that's widely used in Latin America. But when Martin Shkreli took interest, those doctors panicked — then mobilized.(Image credit: Ray Coleman/Science Source) (Source: NPR Health and Science)
Source: NPR Health and Science - September 10, 2017 Category: Consumer Health News Authors: Courtney Columbus Source Type: news
Drug to Treat Chagas Disease to Become Available in the U.S.
Press releaseDrug to Treat Chagas Disease to Become Available in the U.S.August 31, 2017Pharmaceutical company Chemo Group announced today that it will make a drug to treat the neglected tropical disease Chagas available to people in the United States. The U.S. Food and Drug Administration ’s (FDA) approval of the drug, benznidazole, means that Chagas pediatric patients in the U.S. could receive access to a therapy that Doctors Without Borders/Médecins Sans Frontières (MSF) has been using for decades to treat people living with Chagas across Latin America. Though Chagas affects an estimated 300,000 people in the U.S., ...
Source: MSF News - August 31, 2017 Category: International Medicine & Public Health Authors: Brienne Prusak Source Type: news
U.S. FDA Approves Chemo Group's Benznidazole to Treat Children with Chagas Disease
WASHINGTON D.C., BUENOS AIRES, Argentina, MADRID and GENEVA, August 31, 2017 -- (Healthcare Sales & Marketing Network) -- On August 29th, the U.S. Food and Drug Administration (FDA) approved Chemo Research's New Drug Application (NDA) for benznidazole. Th... Biopharmaceuticals, FDA Chemo Group, benznidazole, Chagas disease (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 31, 2017 Category: Pharmaceuticals Source Type: news
FDA Approves First U.S. Treatment for Chagas Disease (FREE)
By the Editors
The FDA has approved benznidazole to treat Chagas disease, a parasitic infection, in children aged 2 to 12 years.The disease … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - August 30, 2017 Category: Primary Care Source Type: news
FDA Approves 1st Treatment for'Kissing Bug' Illness in Children
Benznidazole becomes the nation's only drug for Chagas disease Source: HealthDay Related MedlinePlus Pages: Chagas Disease, Children's Health (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - August 30, 2017 Category: Consumer Health News Source Type: news
FDA approves first U.S. treatment for Chagas disease
The U.S. Food and Drug Administration has granted accelerated approval to benznidazole for use in children ages 2 to 12 years old with Chagas disease. It is the first treatment approved in the United States for the treatment of Chagas disease. Chagas disease, or American trypanosomiasis, is a parasitic infection caused by Trypanosoma cruzi and can be transmitted through different routes, (Source: World Pharma News)
Source: World Pharma News - August 30, 2017 Category: Pharmaceuticals Tags: Featured FDA Regulatory Affairs Source Type: news
That drug meant to transform Martin Shkreli's former Bay Area company? Someone else got to it first
A Peninsula company once led by "pharma bad boy" Martin Shkreli had hoped to bring this drug to the United States to treat Chagas disease. A group of for-profit and non-profit interests beat it to the punch. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - August 30, 2017 Category: Biotechnology Authors: Ron Leuty Source Type: news
That drug meant to transform Martin Shkreli's former Bay Area company? Someone else got to it first
A Peninsula company once led by "pharma bad boy" Martin Shkreli had hoped to bring this drug to the United States to treat Chagas disease. A group of for-profit and non-profit interests beat it to the punch. (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - August 30, 2017 Category: Health Management Authors: Ron Leuty Source Type: news
